Bobbins A, Davies M, Lynn E, Roy D, Yeomans A, Shakir SA. Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective. Br J Clin Pharmacol. 2025 Mar 6; Epub 2025 Mar 6 PubMed.
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.